Pregabalin Completed Phase 2 Trials for Epilepsy, Localization Related Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00141414To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.